DossierENTITY

GLP-1 obesity drugs

Coverage of GLP-1 obesity drugs in the Nexus archive.

Earliest in view: Jul 8 · 13:19 UTCMost recent: Jul 8 · 13:19 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 8 · 13:19 UTCCNBC TOP
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Approximately 36% of employers provide coverage for GLP-1 obesity drugs for both diabetes and weight loss in 2025, unchanged from the previous year and up from 34% in 2024. Many employers are finding ways to avoid expanding this coverage.